Search

Your search keyword '"Mattsson N"' showing total 392 results

Search Constraints

Start Over You searched for: Author "Mattsson N" Remove constraint Author: "Mattsson N"
392 results on '"Mattsson N"'

Search Results

1. High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease

5. CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders.

12. Acute reduction of cerebrospinal fluid volume prior to spinal anesthesia : implications for sensory block extent

18. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

19. Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia

20. Association of Cerebral Amyloid-beta Aggregation With Cognitive Functioning in Persons Without Dementia

21. Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia

23. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

24. Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease

25. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

26. Association of Cerebral Amyloid-beta Aggregation With Cognitive Functioning in Persons Without Dementia

27. Preclinical effects of APOE [epsilon]4 on cerebrospinal fluid Aß42 concentrations

28. Validation of the short forms of the Pelvic Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) in Finnish

32. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

33. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis

34. Predicting reduction of cerebrospinal fluid β-Amyloid 42 in Cognitively healthy controls

35. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

36. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis

37. Results of voluntary cardiovascular examination of elite athletes in Denmark:Proposal for Nordic collaboration

38. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

39. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

41. Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease

42. EURObservational Research Programme:regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

43. EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

44. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

47. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

48. Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

49. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

50. Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

Catalog

Books, media, physical & digital resources